- Receive your unique join code via email
- Create a profile on the app (using the email you registered with)
- Enter your details
- Complete matchmaking
- Navigate to the 'People' tab
- Select a profile you want to connect with
- Click 'Connect +'
- Then select 'Suggest meeting'
Your Title Here
Event app
Launching on Thursday 24th April 2025
Powerful and relevant networking experience
The US Pharma and Biotech Summit's event and networking app is powered by Brella, an award-winning networking tool that allows you to schedule one-on-one meetings with the most relevant attendees. Download the app to fill your day with informative discussions and relevant 1:1 meetings with other industry professionals.
All registered delegates will receive their unique joining code and link on Thursday 24th April 2025.
In-person attendees
Live broadcast
See companies attending
Send messages
Schedule meetings
All registered attendees will receive their unique joining code on Thursday 24th April
Digital attendees
Live broadcast
See companies attending
Send messages
Schedule meetings
All registered attendees will receive their unique joining code on Thursday 24th April
Digital Attendees - Upgrade your pass to attend in-person and access networking. Contact Hauwra at hauwra.sharif@ft.com or email us at ftlive@ft.com
How to join the FT Live Event App
Schedule a meeting
Once you complete your profile, you’ll see your recommended matches right away.
Remember to check whether they are attending 'in-person' or 'virtually' by checking out their profile and attendance type.
Connect in-person or online!
Start exploring the event app and see who you could be meeting in-person or connecting with online.
Download the FT Live Event App
Ahead of the event you can download the FT Live Event App on the App Store or Google Play.
Once you have created your profile, sign in to the app by entering the Email Address you registered to the event with.
Any Questions?
Contact us
+44 (0) 207 775 6653
ftlive@ft.com
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice